@article{ATM6828,
author = {Tu Dan and Joshua Palmer},
title = {Targeted drug combinations: avant-garde oncology},
journal = {Annals of Translational Medicine},
volume = {3},
number = {11},
year = {2015},
keywords = {},
abstract = {In this year’s most prominent oncology conferences, an emerging theme amongst leading abstracts was the increasing use of combination targeted therapy. Spurred by a presidential call for precision medicine, leading researchers are now exploring the use of a combination of targeted agents to simultaneously attack multiple cancer pathways. This strategy has been most exemplified in the case of cancer immunotherapy, as a number of groundbreaking studies in the clinical arena have demonstrated the promise and superiority of combination therapy.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/6828}
}